{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T20:13:31Z","timestamp":1762460011150,"version":"3.41.0"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,10]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>Digital medicine (mHealth) aims to help patients and healthcare providers (HCPs) improve and facilitate the provision of patient care. It encompasses equipment\/connected medical devices, mHealth services and mHealth apps (apps). An updated review on digital health in anaphylaxis is proposed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>In anaphylaxis, mHealth is used in electronic health records and registries.<\/jats:p>\n            <jats:p>It will greatly benefit from the new International Classification of Diseases-11 rules and artificial intelligence. Telehealth has been revolutionised by the coronavirus disease 2019 pandemic, and lessons learnt should be extended to shared decision making in anaphylaxis. Very few nonvalidated apps exist and there is an urgent need to develop and validate such tools.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>Although digital health appears to be of great importance in anaphylaxis, it is still insufficiently used.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/aci.0000000000000764","type":"journal-article","created":{"date-parts":[[2021,7,22]],"date-time":"2021-07-22T14:06:43Z","timestamp":1626962803000},"page":"448-454","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":8,"title":["Anaphylaxis and digital medicine"],"prefix":"10.1097","volume":"21","author":[{"given":"Aram","family":"Anto","sequence":"first","affiliation":[{"name":"MASK-air, Montpellier, France"}]},{"given":"Bernardo","family":"Sousa-Pinto","sequence":"additional","affiliation":[{"name":"MEDCIDS \u2013 Department of Community Medicine, Information and Health Decision Sciences, Faculty of Medicine, University of Porto"},{"name":"CINTESIS \u2013 Center for Health Technology and Services Research"},{"name":"RISE \u2013 Health Research Network; University of Porto, Porto, Portugal"}]},{"given":"Jean","family":"Bousquet","sequence":"additional","affiliation":[{"name":"MASK-air, Montpellier, France"},{"name":"Charit\u00e9, Universit\u00e4tsmedizin Berlin, Humboldt-Universit\u00e4t zu Berlin, and Berlin Institute of Health, Comprehensive Allergy Center, Department of Dermatology and Allergy, Berlin, Germany"},{"name":"University Hospital Montpellier, France"}]}],"member":"276","published-online":{"date-parts":[[2021,7,20]]},"reference":[{"key":"R4-20250527","doi-asserted-by":"crossref","first-page":"e18513","DOI":"10.2196\/18513","article-title":"Mobile health apps for medical emergencies: systematic review","volume":"8","author":"Plaza Roncero","year":"2020","journal-title":"JMIR Mhealth Uhealth"},{"key":"R5-20250527","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jaip.2018.06.010","article-title":"Drug-induced anaphylaxis documented in electronic health records","volume":"7","author":"Dhopeshwarkar","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"R6-20250527","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13601-020-00317-y","article-title":"EAACI Task force Clinical epidemiology of anaphylaxis: experts\u2019 perspective on the use of adrenaline autoinjectors in Europe","volume":"10","author":"Kraft","year":"2020","journal-title":"Clin Transl Allergy"},{"key":"R7-20250527","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13601-019-0259-6","article-title":"Adverse drug reaction classification by health professionals: appropriate discrimination between allergy and intolerance?","volume":"9","author":"Shakib","year":"2019","journal-title":"Clin Transl Allergy"},{"key":"R8-20250527","doi-asserted-by":"crossref","first-page":"e00550","DOI":"10.1002\/prp2.550","article-title":"Categorization of adverse drug reactions in electronic health records","volume":"8","author":"Foreman","year":"2020","journal-title":"Pharmacol Res Perspect"},{"key":"R9-20250527","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1097\/EDE.0000000000001330","article-title":"Identification and validation of anaphylaxis using electronic health data in a population-based setting","volume":"32","author":"Bann","year":"2021","journal-title":"Epidemiology"},{"key":"R10-20250527","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.jaci.2019.05.013","article-title":"Changing the history of anaphylaxis mortality statistics through the World Health Organization's International Classification of Diseases-11","volume":"144","author":"Tanno","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"R11-20250527","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13023-016-0554-4","article-title":"Fatal anaphylaxis registries data support changes in the who anaphylaxis mortality coding rules","volume":"12","author":"Tanno","year":"2017","journal-title":"Orphanet J Rare Dis"},{"key":"R12-20250527","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/ACI.0000000000000722","article-title":"Epidemiology of anaphylaxis","volume":"21","author":"Tanno","year":"2021","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"R13-20250527","doi-asserted-by":"crossref","first-page":"676.e1","DOI":"10.1016\/j.jaip.2020.09.062","article-title":"A proposal from the Montpellier World Health Organization Collaborating Centre for better management and prevention of anaphylaxis","volume":"9","author":"Tanno","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"R14-20250527","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jbi.2018.09.012","article-title":"Predicting of anaphylaxis in big data EMR by exploring machine learning approaches","volume":"87","author":"Segura-Bedmar","year":"2018","journal-title":"J Biomed Inform"},{"key":"R15-20250527","doi-asserted-by":"crossref","first-page":"e2022836","DOI":"10.1001\/jamanetworkopen.2020.22836","article-title":"Development and validation of a deep learning model for detection of allergic reactions using safety event reports across hospitals","volume":"3","author":"Yang","year":"2020","journal-title":"JAMA Netw Open"},{"key":"R16-20250527","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1111\/all.14560","article-title":"Usefulness of an artificial neural network to assess anaphylaxis severity","volume":"76","author":"Kraft","year":"2021","journal-title":"Allergy"},{"key":"R17-20250527","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.3346\/jkms.2021.36.e67","article-title":"Estimating baseline incidence of conditions potentially associated with vaccine adverse events: a call for surveillance system using the Korean National Health Insurance Claims Data","volume":"36","author":"Huh","year":"2021","journal-title":"J Korean Med Sci"},{"key":"R18-20250527","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1001\/jama.2021.0600","article-title":"Allergic reactions including anaphylaxis after receipt of the first dose of Pfizer-BioNTech COVID-19 vaccine","volume":"325","author":"Shimabukuro","year":"2021","journal-title":"JAMA"},{"key":"R19-20250527","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1016\/j.jaip.2020.05.009","article-title":"The future of telehealth in allergy and immunology training","volume":"8","author":"Keswani","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"R20-20250527","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1159\/000512079","article-title":"Change in allergy practice during the COVID-19 pandemic","volume":"182","author":"Ozturk","year":"2021","journal-title":"Int Arch Allergy Immunol"},{"key":"R21-20250527","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1111\/all.14453","article-title":"COVID-19 pandemic: practical considerations on the organization of an allergy clinic\u2014an EAACI\/ARIA position paper","volume":"76","author":"Pfaar","year":"2021","journal-title":"Allergy"},{"key":"R22-20250527","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1007\/s40521-021-00284-0","article-title":"Management of Anaphylaxis During the SARS-CoV-2 Pandemic","volume":"8","author":"Brar","year":"2021","journal-title":"Curr Treat Options Allergy"},{"key":"R23-20250527","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1016\/j.jaip.2020.07.016","article-title":"Managing food allergy in schools during the COVID-19 pandemic","volume":"8","author":"Greenhawt","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"R24-20250527","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1016\/j.jaip.2020.07.020","article-title":"Novel approaches to food allergy management during COVID-19 inspire long-term change","volume":"8","author":"Mack","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"R25-20250527","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1016\/j.jaip.2020.04.022","article-title":"Acute at home management of anaphylaxis during the COVID-19 pandemic","volume":"8","author":"Casale","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"R26-20250527","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/all.13953","article-title":"The role of mobile health technologies in allergy care: an EAACI position paper","volume":"75","author":"Matricardi","year":"2020","journal-title":"Allergy"},{"key":"R27-20250527","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1111\/all.14626","article-title":"Digital technology for anaphylaxis management impact on patient behaviour: a randomized clinical trial","volume":"76","author":"Sala-Cunill","year":"2021","journal-title":"Allergy"},{"key":"R28-20250527","doi-asserted-by":"crossref","first-page":"e13414","DOI":"10.2196\/13414","article-title":"Proximity-based emergency response communities for patients with allergies who are at risk of anaphylaxis: clustering analysis and scenario-based survey study","volume":"7","author":"Gaziel Yablowitz","year":"2019","journal-title":"JMIR Mhealth Uhealth"},{"key":"R29-20250527","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1016\/j.jaip.2019.07.044","article-title":"Mobile technology in allergic rhinitis: evolution in management or revolution in health and care?","volume":"7","author":"Bousquet","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"R30-20250527","doi-asserted-by":"crossref","first-page":"e13892","DOI":"10.2196\/13892","article-title":"Childrens\u2019 and parents\u2019 willingness to join a smartphone-based emergency response community for anaphylaxis: survey","volume":"7","author":"Khalemsky","year":"2019","journal-title":"JMIR Mhealth Uhealth"},{"key":"R31-20250527","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1136\/bmjqs-2016-005879","article-title":"Exploring the roots of unintended safety threats associated with the introduction of hospital ePrescribing systems and candidate avoidance and\/or mitigation strategies: a qualitative study","volume":"26","author":"Mozaffar","year":"2017","journal-title":"BMJ Qual Saf"},{"key":"R32-20250527","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1089\/tmj.2018.0046","article-title":"Life-threatening allergies: using a patient-engaged approach","volume":"25","author":"Gallagher","year":"2019","journal-title":"Telemed J E Health"},{"key":"R33-20250527","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1109\/JBHI.2015.2497717","article-title":"Evaluation of AllergiSense smartphone tools for adrenaline injection training","volume":"21","author":"Hernandez-Munoz","year":"2017","journal-title":"IEEE J Biomed Health Inform"},{"key":"R34-20250527","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1097\/ACI.0000000000000575","article-title":"\u2019Googling\u2019 anaphylaxis","volume":"19","author":"Kornafeld","year":"2019","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"R42-20250527","doi-asserted-by":"crossref","first-page":"e15588","DOI":"10.2196\/15588","article-title":"Benefits and disadvantages of electronic patient-reported outcome measures: systematic review","volume":"3","author":"Meirte","year":"2020","journal-title":"JMIR Perioper Med"}],"container-title":["Current Opinion in Allergy &amp; Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/ACI.0000000000000764","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T18:07:54Z","timestamp":1748369274000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/ACI.0000000000000764"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,20]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/aci.0000000000000764","relation":{},"ISSN":["1528-4050","1473-6322"],"issn-type":[{"type":"print","value":"1528-4050"},{"type":"electronic","value":"1473-6322"}],"subject":[],"published":{"date-parts":[[2021,7,20]]}}}